Your browser doesn't support javascript.
loading
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan.
Ishizawa, Kenichi; Yokoyama, Masahiro; Kato, Harumi; Yamamoto, Kazuhito; Makita, Masanori; Ando, Kiyoshi; Ueda, Yasunori; Tachikawa, Yoshimichi; Suehiro, Youko; Kurosawa, Mitsutoshi; Kameoka, Yoshihiro; Nagai, Hirokazu; Uoshima, Nobuhiko; Ishikawa, Takayuki; Hidaka, Michihiro; Ito, Yoshikiyo; Utsunomiya, Atae; Fukushima, Koji; Ogura, Michinori.
Afiliação
  • Ishizawa K; Department of Hematology, Yamagata University Hospital, Yamagata, Japan. kishizaw@med.id.yamagata-u.ac.jp.
  • Yokoyama M; Department of Hematology Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kato H; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Makita M; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Ando K; Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan.
  • Ueda Y; Department of Hematology/Oncology, Ohara HealthCare Foundation Kurashiki Central Hospital, Kurashiki, Japan.
  • Tachikawa Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Kurosawa M; Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Kameoka Y; Department of Hematology, Akita University Hospital, Akita, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Ito Y; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Fukushima K; SymBio Pharmaceuticals Limited, Tokyo, Japan.
  • Ogura M; Department of Hematology and Oncology, Kasugai Municipal Hospital, Kasugai, Japan.
Cancer Chemother Pharmacol ; 90(1): 83-95, 2022 07.
Article em En | MEDLINE | ID: mdl-35796785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Linfoma de Célula do Manto / Cloridrato de Bendamustina / Recidiva Local de Neoplasia Limite: Adult / Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B / Linfoma de Célula do Manto / Cloridrato de Bendamustina / Recidiva Local de Neoplasia Limite: Adult / Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article